Remove Bioassay Remove Development Remove Gene Remove Genomics
article thumbnail

4th Gene Therapy Analytical Development Summit 2022

pharmaphorum

The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. If you work in quality control, quality assurance, or process development – we’ve listened and we’ve answered. Download the full event guide to find out more.

article thumbnail

Evaluating methods targeting Protein-Protein Interactions

pharmaphorum

The issue, however, is developing an effective way of targeting them. . Understanding the mechanism of PPIs and developing methods to target aberrant ones has been a key strategy in drug development. The flat interface remains the primary challenge facing the development of PPI modulators.

Protein 126
article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. Here, new bioassay technologies helped testing, but more definite answers were required. Often drug targets already validated in academic literature are picked up for drug discovery and development efforts.